Adaptive trial designs improve efficiency by potentially reducing the number of patients needed and shortening the duration of the trial. For instance, if a treatment shows early signs of efficacy, the trial can be modified to focus more on that treatment, thereby reducing the need for continued testing of less effective options. This can be particularly beneficial in neonatal clinical trials where participant numbers are limited.
